Conmed CNMD
NYSE CNMD
$51.39 +0.14 (+0.27%)
At close: Aug 20, 2026 · 2:17 PM UTC

Conmed (CNMD) EBT Margin (2010 - 2026)

Conmed's (CNMD) quarterly EBT Margin came in at 9.13% in Q2 2026, up 39.0% YoY from 6.57% in Q2 2025, and up 57.63% on a QoQ basis from 5.79% in Q1 2026.

Conmed (CNMD) EBT Margin (2010 - 2026) Analysis & Trends

Conmed (CNMD) has 17 years of EBT Margin data on file, last reported at 9.13% in Q2 2026.

  • Quarterly EBT Margin rose 39.0% year-over-year to 9.13% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 6.07% (down 431.0% YoY) and the FY2025 annual result came in at 5.17%, down 730.0% from the prior year.
  • EBT Margin climbed to 9.13% in Q2 2026, from 5.79% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 17.83% in Q3 2024 to a low of 33.72% in Q2 2022.
  • A 5-year average of 4.75% and a median of 6.93% in 2023 frame the typical range for EBT Margin.
  • Annual changes were most pronounced in 2022 — EBT Margin tumbled 4011 bps — and 2023, when it surged 3921 bps.
  • Tracing CNMD's EBT Margin over 5 years: stood at 4.2% in 2022, then jumped by 396 bps to 12.44% in 2023, then advanced by 1 bps to 12.62% in 2024, then plunged by 38 bps to 7.84% in 2025, then rose by 16 bps to 9.13% in 2026.
  • The last three EBT Margin figures came in at 9.13% (Q2 2026), 5.79% (Q1 2026), and 7.84% (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Abbott Laboratories 199.61 Bn 194.01 Bn 7.27 Bn 12.10%
2 Stryker 127.81 Bn 124.34 Bn 4.50 Bn 23.74%
3 Medtronic 119.04 Bn 109.82 Bn 6.41 Bn 18.70%
4 Boston Scientific 73.68 Bn 73.14 Bn 3.85 Bn 19.48%
5 Edwards Lifesciences 51.96 Bn 47.71 Bn 1.35 Bn 29.86%
6 Dexcom 34.36 Bn 32.41 Bn 830.00 Mn 24.27%
7 GE HealthCare Technologies 33.83 Bn 31.72 Bn 2.18 Bn 13.09%
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn 8.91%
9 Steris 23.06 Bn 22.58 Bn 684.20 Mn 18.32%
10 Conmed 1.54 Bn 1.51 Bn 197.46 Mn 9.13%

Historic Data

Download Data
DateValue
Jun 30, 2026 9.13%
Mar 31, 2026 5.79%
Dec 31, 2025 7.84%
Sep 30, 2025 1.26%
Jun 30, 2025 8.74%
Mar 31, 2025 2.39%
Dec 31, 2024 12.62%
Sep 30, 2024 17.83%
Jun 30, 2024 11.30%
Mar 31, 2024 8.14%
Dec 31, 2023 12.44%
Sep 30, 2023 6.66%
Jun 30, 2023 5.48%
Mar 31, 2023 0.83%
Dec 31, 2022 -4.20%
Sep 30, 2022 5.71%
Jun 30, 2022 -33.72%
Mar 31, 2022 7.20%
Dec 31, 2021 10.82%
Sep 30, 2021 7.01%